305 related articles for article (PubMed ID: 26672604)
1. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials.
Wang ZQ; Zhang R; Zhang PP; Liu XH; Sun J; Wang J; Feng XF; Lu QF; Li YG
J Cardiovasc Pharmacol; 2015 Apr; 65(4):364-70. PubMed ID: 25551322
[TBL] [Abstract][Full Text] [Related]
3. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
Tang T; Liu J; Zuo K; Cheng J; Chen L; Lu C; Han S; Xu J; Jia Z; Ye M; Pei E; Zhang X; Li M
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):387-94. PubMed ID: 25575537
[TBL] [Abstract][Full Text] [Related]
4. Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.
Yang T; Zhou Y; Chen C; Lu M; Ma L; Cui Y
J Clin Pharm Ther; 2019 Apr; 44(2):197-208. PubMed ID: 30593674
[TBL] [Abstract][Full Text] [Related]
5. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Stergiopoulos K; Brown DL
JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin.
Dahal K; Sharma SP; Fung E; Lee J; Moore JH; Unterborn JN; Williams SM
Chest; 2015 Sep; 148(3):701-710. PubMed ID: 25811981
[TBL] [Abstract][Full Text] [Related]
7. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.
Tse G; Gong M; Li G; Wong SH; Wu WKK; Wong WT; Roever L; Lee APW; Lip GYH; Wong MCS; Liu T;
Br J Clin Pharmacol; 2018 Sep; 84(9):1868-1882. PubMed ID: 29704269
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Genotype-Guided Warfarin Dosing in the Chinese Population: A Meta-analysis of Randomized Controlled Trials.
Wang F; Guo J; Zhang A
J Cardiovasc Pharmacol; 2019 Mar; 73(3):127-135. PubMed ID: 30688796
[TBL] [Abstract][Full Text] [Related]
9. Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials.
Li X; Yang J; Wang X; Xu Q; Zhang Y; Yin T
Thromb Res; 2015 Apr; 135(4):621-9. PubMed ID: 25628141
[TBL] [Abstract][Full Text] [Related]
10. Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.
Tang HL; Shi WL; Li XG; Zhang T; Zhai SD; Xie HG
Pharmacogenomics J; 2015 Dec; 15(6):496-504. PubMed ID: 25869011
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
[TBL] [Abstract][Full Text] [Related]
12. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.
Wang X; Tang B; Zhou M; Liu L; Feng X; Wang X; Qiu K
Thromb Res; 2022 Feb; 210():42-52. PubMed ID: 34999431
[TBL] [Abstract][Full Text] [Related]
14. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing.
Liao Z; Feng S; Ling P; Zhang G
J Thromb Thrombolysis; 2015 Feb; 39(2):228-34. PubMed ID: 24962733
[TBL] [Abstract][Full Text] [Related]
17. Meta-Analysis of Genotype-Guided Versus Standard Dosing of Vitamin K Antagonists.
Kheiri B; Abdalla A; Haykal T; Osman M; Ahmed S; Hassan M; Bachuwa G
Am J Cardiol; 2018 Apr; 121(7):879-887. PubMed ID: 29402419
[TBL] [Abstract][Full Text] [Related]
18. Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.
Franchini M; Mengoli C; Cruciani M; Bonfanti C; Mannucci PM
J Thromb Haemost; 2014 Sep; 12(9):1480-7. PubMed ID: 25040440
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K for improved anticoagulation control in patients receiving warfarin.
Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.
Kangelaris KN; Bent S; Nussbaum RL; Garcia DA; Tice JA
J Gen Intern Med; 2009 May; 24(5):656-64. PubMed ID: 19306050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]